Transcriptomics

Dataset Information

0

Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene-edited mice


ABSTRACT: Duchenne Muscular Dystrophy (DMD) is a lethal muscle disease caused by mutations in the dystrophin gene. CRISPR/Cas9 genome-editing has been used to correct DMD mutations in animal models at young ages. However, the longevity and durability of CRISPR/Cas9 editing remained to be determined. To address these issues, we subjected DEx44 DMD mice to systemic delivery of AAV9 expressing CRISPR/Cas9 gene editing components to reframe exon 45 of the dystrophin gene, allowing robust dystrophin expression and maintenance of muscle structure and function. We showed that genome correction by CRISPR/Cas9 confers lifelong expression of dystrophin in mice and that corrected skeletal muscle is highly durable and resistant to myofiber necrosis and fibrosis, even in response to chronic injury. In contrast, when muscle fibers were ablated by barium chloride injection, satellite cells were unable to restore dystrophin expression due to restriction of gene editing components. Analysis of on-target and off-target gene editing in aged mice confirmed the stability of gene correction and the lack of significant off-target editing at 18 months of age. These findings demonstrate the long-term durability of CRISPR/Cas9 genome editing as a therapy for maintaining the integrity and function of DMD muscle, even under conditions of stress.

ORGANISM(S): Mus musculus

PROVIDER: GSE180771 | GEO | 2021/07/27

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-02-28 | GSE167584 | GEO
2021-02-28 | GSE167583 | GEO
2021-02-28 | GSE167572 | GEO
2021-02-28 | GSE167586 | GEO
2021-02-28 | GSE167585 | GEO
2021-08-02 | GSE169551 | GEO
2021-08-06 | GSE169190 | GEO
2023-07-11 | PXD039533 | Pride
2024-05-30 | GSE262976 | GEO
2020-02-05 | PXD014893 | Pride